ORY-1001 trans and cis isomers
CAS No. 1431326-61-2
ORY-1001 trans and cis isomers( RG 6016 | RG6016 | RG-6016 | ORY1001 | ORY 1001 )
Catalog No. M11827 CAS No. 1431326-61-2
ORY-1001 (RG-6016) is a highly potent, selective inhibitor of lysine-specific demethylase KDM1A (LSD1) with IC50 of 18 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 68 | In Stock |
|
| 5MG | 122 | In Stock |
|
| 10MG | 221 | In Stock |
|
| 25MG | 428 | In Stock |
|
| 50MG | 626 | In Stock |
|
| 100MG | 889 | In Stock |
|
| 500MG | 1782 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameORY-1001 trans and cis isomers
-
NoteResearch use only, not for human use.
-
Brief DescriptionORY-1001 (RG-6016) is a highly potent, selective inhibitor of lysine-specific demethylase KDM1A (LSD1) with IC50 of 18 nM.
-
DescriptionORY-1001 (RG-6016) is a highly potent, selective inhibitor of lysine-specific demethylase KDM1A (LSD1) with IC50 of 18 nM, displays high selectivity for KDM1A over other FAD-containing monoamine oxidases; exhibits low nanomolar cellular activity (EC50 < 1 nM) in the THP1 differentiation assay and induces the CD11b marker within 6 hr of treatment in FACS based differentiation assay in THP1 cell line; induces H3K4me2 accumulation on KDM1A target genes, blast differentiation, and reduction of leukemic stem cell capacity in AML; exhibits potent synergy with standard-of-care drugs and selective epigenetic inhibitors, reduces growth of AML xenograft models.Blood Cancer Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsRG 6016 | RG6016 | RG-6016 | ORY1001 | ORY 1001
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorLSD1/KDM1A
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1431326-61-2
-
Formula Weight303.2704
-
Molecular FormulaC15H24Cl2N2
-
Purity>98% (HPLC)
-
SolubilityDMSO: < 6.8 mg/mL
-
SMILESNC1CCC(N[C@@H]2C[C@H]2C3=CC=CC=C3)CC1.Cl.Cl
-
Chemical Name1,4-Cyclohexanediamine, N1-[(1R,2S)-2-phenylcyclopropyl]-, hydrochloride (1:2), rel-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Maes T, et al. Cancer Cell. 2018 Mar 12;33(3):495-511.e12.
molnova catalog
related products
-
Bizine
Bizine is a phenelzine analog that inhibits LSD1 with Ki of 59 nM.
-
GSK-2879552
A potent, selective irreversible inhibitor of LSD1 with Ki app of 1.7 uM.
-
KHK-IN-2
KHK-IN-2 is a selective and potent ketohexokinase (KHK) inhibitor with an IC50 of 0.45 μM.
Cart
sales@molnova.com